The latest closing stock price for Dianthus Therapeutics as of January 21, 2025 is 21.66.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-907 today, roughly -1 times their original investment - a -28.75% compound annual growth rate over 7 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 33.77, which is 55.9% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 16.39, which is 24.3% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 25.49.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-907 today, roughly -1 times their original investment - a -28.75% compound annual growth rate over 7 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 33.77, which is 55.9% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 16.39, which is 24.3% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 25.49.